(Q44758081)

English

Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study

scientific article published in February 2004

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Tamoxifen-associated malignant endometrial tumors: pathologic features and expression of hormone receptors estrogen-alpha, estrogen-beta and progesterone; a case controlled study (English)

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

1 reference

based on heuristic

inferred from title

Charlotte Kaetzel

8

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Richard John Kryscio

11

object named as

Richard J Kryscio

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

author name string

James L Wilder

1

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Shahin Shajahan

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Nada H Khattar

3

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Dawn M Wilder

4

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Jianming Yin

5

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Rodney S Rushing

6

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Rick Beaven

7

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Frederick R Ueland

9

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

John R van Nagell

10

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Subodh M Lele

12

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

language of work or name

0 references

publication date

1 February 2004

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Gynecologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

92

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

553-558

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Cloning of a novel receptor expressed in rat prostate and ovary

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.10.040

7 January 2021

Role of estrogen receptor beta in estrogen action

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.10.040

7 January 2021

Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.10.040

7 January 2021

Opposing action of estrogen receptors alpha and beta on cyclin D1 gene expression

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.10.040

7 January 2021

Prolonged treatment of breast cancer cells with antiestrogens increases the activating protein-1-mediated response: involvement of the estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.10.040

7 January 2021

The expression of Fhit protein is related inversely to disease progression in patients with breast carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.10.040

7 January 2021

Cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.10.040

7 January 2021

Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.10.040

7 January 2021

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.10.040

7 January 2021

Tamoxifen in the treatment of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.10.040

7 January 2021

High-grade endometrial carcinoma in tamoxifen-treated breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.10.040

7 January 2021

Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC).

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.10.040

7 January 2021

Tamoxifen-related uterine carcinosarcomas occur under/after prolonged treatment: report of five cases and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.10.040

7 January 2021

A realistic clinical perspective of tamoxifen and endometrial carcinogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.10.040

7 January 2021

Tamoxifen treatment and gynecologic side effects: a review

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.10.040

7 January 2021

The endometrium in breast cancer patients on tamoxifen.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.10.040

7 January 2021

Endocrine therapy for advanced breast cancer: a review

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.10.040

7 January 2021

Oestrogen receptor beta expression and depth of myometrial invasion in human endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.10.040

7 January 2021

Changes in expression of estrogen receptors alpha and beta in relation to progesterone receptor and pS2 status in normal and malignant endometrium.

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.10.040

7 January 2021

Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres' ALERT Group. Assessment of Liver and Endometrial cancer Risk following Tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.10.040

7 January 2021

Clinical implications of the expression of estrogen receptor-alpha and -beta in primary and metastatic lesions of uterine endometrial cancers

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2003.10.040

7 January 2021

Identifiers

10.1016/J.YGYNO.2003.10.040

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

6 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44758081&oldid=2191045605"